Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nima Sharifai

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Brain Pathology (Zurich, Switzerland)|November 13, 2018
Clinicopathologic features of anaplastic myxopapillary ependymomasJulieann C Lee, Nima Sharifai, Sonika Dahiya, et al.
Neuro-Oncology Advances|March 19, 2026
The TNFR superfamily member Fn14 impacts immunity and survival in experimental gliomas and response to immune checkpoint inhibitor therapy in glioblastoma patientsPranjali P Kanvinde, Adarsha P Malla, Alexandra A Seas, et al.
The American Journal of Surgical Pathology|April 21, 2026
Enteroblastic and Hepatoid Colorectal Carcinomas are Aggressive Cancers With a Distinctive Immunophenotype, While Clear Cell Carcinoma Appears to Represent Clear Cell Change in Conventional Colorectal CancerFahad Khan, Alexandros D Polydorides, John D Paulsen, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Brain Pathology (Zurich, Switzerland)|November 13, 2018
Clinicopathologic features of anaplastic myxopapillary ependymomasJulieann C Lee, Nima Sharifai, Sonika Dahiya, et al.
Neuro-Oncology Advances|March 19, 2026
The TNFR superfamily member Fn14 impacts immunity and survival in experimental gliomas and response to immune checkpoint inhibitor therapy in glioblastoma patientsPranjali P Kanvinde, Adarsha P Malla, Alexandra A Seas, et al.
The American Journal of Surgical Pathology|April 21, 2026
Enteroblastic and Hepatoid Colorectal Carcinomas are Aggressive Cancers With a Distinctive Immunophenotype, While Clear Cell Carcinoma Appears to Represent Clear Cell Change in Conventional Colorectal CancerFahad Khan, Alexandros D Polydorides, John D Paulsen, et al.
Pageof 3